A specially engineered antibody that can infiltrate kidney cysts has shown the ability to block key growth signals driving ...

Survival rarely comes easy when pancreatic ductal adenocarcinoma strikes. Most people learn of it only after it has spread, ...

Gynecological cancers remain a major threat to women's health, with traditional therapies often having limited effect and ...

Artificial intelligence (AI) and "protein language" models can speed the design of monoclonal antibodies that prevent or reduce the severity of potentially life-threatening viral infections, according ...

By fusing enzyme fragments to antibodies, researchers from the Institute of Science Tokyo, in Japan, developed an innovative ...

They're just one-tenth the size of conventional antibodies, and have not been found in any other mammals, say scientists.

Intravenous immunoglobulin (IVIG) therapy involves infusing patients with naturally occurring IgG antibodies to treat ...

New guidelines recommend doctors tackle Crohn's disease head-on, calling for the use of cutting-edge drugs as early as ...

Discover the emergence of dual-payload ADCs and PDCs, which could mark a significant evolution in targeted therapeutics.

By fusing enzyme fragments to antibodies, researchers from Institute of Science Tokyo, Japan, developed an innovative enzyme ...

The companies have yet to disclose how many programs they plan to collaborate on or what indications they will prioritize.

Primary nephrotic syndrome in adults, including minimal-change nephrotic syndrome, has an incidence of roughly 0.2 to 0.8 per 100,000 person-years. It is characterized by severe proteinuria and ...